8.23.2010

CBI’s Risk-Sharing and Innovative Contracting for Bio/Pharmaceutical conference, 20-21 October 2010 in London

Dear All,

summer is almost over and it's time to get back to some business. I would like to highlight an interesting upcoming event in October.

CBI (The Center for Business Intelligence) is organizing a Risk-Sharing and Innovative Contracting for Bio/Pharmaceutical conference scheduled for 20-21 October 2010 in London at the Hilton London Canary Wharf. They have received much excitement from the market thus far.

I am providing the link with more detailed information.

Best wishes
Ulf

1 comment:

Greg Mills said...

CCSVI Clinic Receives Joint IRB Approval for Aftercare Protocol Study.

Dr. Don Simonson, the Principal Investigator for the study agrees; “Of course there are other reasons that patients restenose, depending on the condition of their veins in the first place, and operator inexperience, so we have designed a study that isolates the aftercare protocol because we feel it may be at least as important, and in any case well worth studying.”
CCSVI Clinic is already sponsoring patients for this protocol with a 10-day stay in the hospital where patients will be imaged daily, post procedure. If there is evidence of re-occlusion, they will be taken back to the OR and re-treated. To comply with the IRB approval, once home, patients will be examined and/or surveyed at regular intervals by a Principle Investigator (PI) for several years after the treatment to study the changes. Patients will have regular consults with the surgeon who performed their procedure as part of the protocol.
More and more MS patients are reporting initial success (including vascular and some neurological differences) as a result of the venous angioplasty (liberation therapy) but then regression to previous symptoms sometimes within weeks post-procedure. It is estimated that the failure rate of the “liberation therapy” may be 50% or higher, even through the most experienced and best-known surgeons. Consequently, there is increasing concern amongst patients that the liberation therapy hypothesis needs to include a post-procedure protocol that is more refined than simply releasing the patient from the hospital or clinic within hours or a day of the procedure. If the study hypothesis is correct, it means that there are many other considerations that indicate a post-procedure stabilization period, re-examination, and re-treatment if necessary.Please log on to http://ccsviclinic.ca/?p=830 for more information.